Market Overview

Benzinga's Top Pre-Market Losers

Related RVBD
JP Morgan Positive On Brocade Communications' Intent To Acquire SteelApp Assets
Riverbed Technology Beats Q4 EPS Expectations
Related OPTR
HSR Waiting Period Expires for Cubist, Optimer Deal
Cubist Pharma Reports Pricing of $700M in Convertible Senior Notes, Expecting Proceeds of $679M

Riverbed Technology (NASDAQ: RVBD) dipped 17.46% to $14.47 in the pre-market session after the company reported downbeat second-quarter revenue.

Optimer Pharmaceuticals (NASDAQ: OPTR) shares fell 6.47% to $12.43 in the pre-market trading after Cubist Pharmaceuticals (NASDAQ: CBST) announced its plans to acquire Trius Therapeutics (NASDAQ: TSRX) and Optimer for up to $1.62 billion.

BioCryst Pharmaceuticals (NASDAQ: BCRX) shares dropped 5.78% to $3.75 in pre-market trading after the company announced its plans to sell up to $20 million in common stock.

Genworth Financial (NYSE: GNW) dipped 3.82% to $12.85 in the pre-market session after the company reported weaker-than-expected second-quarter results.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (BCRX + CBST)

Around the Web, We're Loving...